PTJ
MDGL icon

Paul Tudor Jones’s Madrigal Pharmaceuticals MDGL Stock Holding History

Paul Tudor Jones’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.18M Sell
11,509
-121
-1% -$62K 0.01% 1139
2026
Q1 		$6.09M Buy
11,630
+6,345
+120% +$3.03M 0.01% 1052
2025
Q4 		$3.08M Buy
5,285
+4,359
+471% +$2.23M 0.01% 1488
2025
Q3 		$425K Buy
+926
New +$345K ﹤0.01% 2780
2025
Q1 		– Sell
-10,327
Closed -$3.39M – 3401
2024
Q4 		$3.19M Buy
+10,327
New +$2.9M 0.01% 941
2024
Q2 		– Sell
-3,258
Closed -$776K – 2596
2024
Q1 		$870K Buy
+3,258
New +$768K 0.01% 1402
2023
Q4 		– Sell
-4,692
Closed -$685K – 2670
2023
Q3 		$685K Buy
4,692
+1,473
+46% +$277K 0.01% 1514
2023
Q2 		$744K Sell
3,219
-9,610
-75% -$2.6M 0.01% 1490
2023
Q1 		$3.11M Buy
12,829
+4,384
+52% +$1.19M 0.05% 573
2022
Q4 		$2.45M Buy
8,445
+617
+8% +$60.3K 0.05% 525
2022
Q3 		$509K Buy
7,828
+11
+0.1% +$764 0.01% 1384
2022
Q2 		$560K Buy
+7,817
New +$575K 0.01% 1219
2022
Q1 		– Sell
-8,536
Closed -$723K – 2414
2021
Q4 		$723K Buy
+8,536
New +$701K 0.01% 1212
2020
Q1 		– Sell
-5,589
Closed -$509K – 1210
2019
Q4 		$509K Buy
+5,589
New +$542K 0.02% 711
2015
Q2 		– Sell
-5,714
Closed -$388K – 1597
2015
Q1 		$388K Buy
+5,714
New +$490K 0.01% 899
2013
Q3 		– Sell
-531
Closed -$93K – 904
2013
Q2 		$93K Buy
+531
New +$138K 0.01% 765

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Paul Tudor Jones's MDGL Position: Q2 2026 in Review

Paul Tudor Jones reduced its Madrigal Pharmaceuticals (MDGL) stake by 1% in Q2 2026, selling an estimated $62K and leaving 11,509 shares worth $6.18M. The position accounts for 0.01% of the portfolio, ranked #1139.

Paul Tudor Jones first reported a position in MDGL in Q2 2013 and has held it in 16 quarters since. 411 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Paul Tudor Jones held 11,509 shares of Madrigal Pharmaceuticals worth $6.18M as of Q2 2026.
  • Paul Tudor Jones sold 121 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $62K.
  • Madrigal Pharmaceuticals made up 0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #1139 holding.
  • Paul Tudor Jones first reported a position in Madrigal Pharmaceuticals in Q2 2013 and has held it in 16 quarters since.
  • 411 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.